SlideShare ist ein Scribd-Unternehmen logo
1 von 119
17  Blood
Blood Composition ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Blood Composition ,[object Object],[object Object],[object Object],[object Object]
Figure 17.1 1 Withdraw blood and place in tube. 2 Centrifuge the blood sample. Plasma •  55% of whole blood •  Least dense component Buffy coat •  Leukocytes and platelets •  <1% of whole blood Erythrocytes •  45% of whole blood •  Most dense component Formed elements
Physical Characteristics and Volume ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Functions of Blood ,[object Object],[object Object],[object Object],[object Object]
Functions of Blood ,[object Object],[object Object],[object Object],[object Object]
Functions of Blood ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Blood Plasma ,[object Object],[object Object],[object Object],[object Object],[object Object]
Blood Plasma ,[object Object],[object Object],[object Object],[object Object],[object Object]
Formed Elements ,[object Object],[object Object],[object Object],[object Object],[object Object]
Figure 17.2 Platelets Neutrophils Lymphocyte Erythrocytes Monocyte
Erythrocytes ,[object Object],[object Object],[object Object],[object Object],[object Object]
Figure 17.3 2.5 µm 7.5 µm Side view (cut) Top view
Erythrocytes ,[object Object],[object Object],[object Object],[object Object],[object Object]
Erythrocyte Function ,[object Object],[object Object]
Erythrocyte Function ,[object Object],[object Object],[object Object],[object Object],[object Object]
Figure 17.4 Heme group (a) Hemoglobin consists of globin (two alpha and two beta polypeptide chains) and four heme groups. (b) Iron-containing heme pigment.    Globin chains    Globin chains
Hemoglobin (Hb) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Hematopoiesis ,[object Object],[object Object]
Hematopoiesis ,[object Object],[object Object],[object Object],[object Object]
Erythropoiesis ,[object Object],[object Object],[object Object]
Erythropoiesis ,[object Object],[object Object],[object Object],[object Object],[object Object]
Figure 17.5 Stem cell Hemocytoblast Proerythro- blast Early erythroblast Late erythroblast Normoblast Phase 1 Ribosome synthesis Phase 2 Hemoglobin accumulation Phase 3 Ejection of nucleus Reticulo- cyte Erythro- cyte Committed cell Developmental pathway
Regulation of Erythropoiesis ,[object Object],[object Object],[object Object],[object Object],[object Object]
Hormonal Control of Erythropoiesis ,[object Object],[object Object],[object Object]
Hormonal Control of Erythropoiesis ,[object Object],[object Object],[object Object],[object Object]
Hormonal Control of Erythropoiesis ,[object Object],[object Object],[object Object],[object Object]
Figure 17.6 Kidney (and liver to a smaller extent) releases erythropoietin. Erythropoietin stimulates red bone marrow. Enhanced erythropoiesis increases RBC count. O 2 - carrying ability of blood increases. Homeostasis:  Normal blood oxygen levels Stimulus: Hypoxia (low blood O 2 - carrying ability) due to •  Decreased RBC count •  Decreased amount of hemoglobin •  Decreased availability of O 2 1 2 3 4 5 IMBALANCE IMBALANCE
Figure 17.6, step 1 Homeostasis:  Normal blood oxygen levels Stimulus: Hypoxia (low blood O 2 - carrying ability) due to •  Decreased RBC count •  Decreased amount of hemoglobin •  Decreased availability of O 2 1 IMBALANCE IMBALANCE
Figure 17.6, step 2 Kidney (and liver to a smaller extent) releases erythropoietin. Homeostasis:  Normal blood oxygen levels Stimulus: Hypoxia (low blood O 2 - carrying ability) due to •  Decreased RBC count •  Decreased amount of hemoglobin •  Decreased availability of O 2 1 2 IMBALANCE IMBALANCE
Figure 17.6, step 3 Kidney (and liver to a smaller extent) releases erythropoietin. Erythropoietin stimulates red bone marrow. Homeostasis:  Normal blood oxygen levels Stimulus: Hypoxia (low blood O 2 - carrying ability) due to •  Decreased RBC count •  Decreased amount of hemoglobin •  Decreased availability of O 2 1 2 3 IMBALANCE IMBALANCE
Figure 17.6, step 4 Kidney (and liver to a smaller extent) releases erythropoietin. Erythropoietin stimulates red bone marrow. Enhanced erythropoiesis increases RBC count. Homeostasis:  Normal blood oxygen levels Stimulus: Hypoxia (low blood O 2 - carrying ability) due to •  Decreased RBC count •  Decreased amount of hemoglobin •  Decreased availability of O 2 1 2 3 4 IMBALANCE IMBALANCE
Figure 17.6, step 5 Kidney (and liver to a smaller extent) releases erythropoietin. Erythropoietin stimulates red bone marrow. Enhanced erythropoiesis increases RBC count. O 2 - carrying ability of blood increases. Homeostasis:  Normal blood oxygen levels Stimulus: Hypoxia (low blood O 2 - carrying ability) due to •  Decreased RBC count •  Decreased amount of hemoglobin •  Decreased availability of O 2 1 2 3 4 5 IMBALANCE IMBALANCE
Dietary Requirements for Erythropoiesis ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Fate and Destruction of Erythrocytes ,[object Object],[object Object],[object Object]
Fate and Destruction of Erythrocytes ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Figure 17.7 Low O 2   levels in blood stimulate  kidneys to produce erythropoietin. 1 Erythropoietin levels rise in blood. 2 Erythropoietin and necessary raw materials in blood promote erythropoiesis in red bone marrow. 3 Aged and damaged red blood cells are engulfed by macrophages of liver, spleen, and bone marrow; the hemoglobin is broken down. 5 New erythrocytes enter bloodstream; function about 120 days. 4 Raw materials are made available in blood for erythrocyte synthesis. 6 Hemoglobin Amino acids Globin Iron is bound to transferrin and released to blood from liver as needed for erythropoiesis. Food nutrients, including amino acids, Fe, B 12 , and folic acid, are absorbed from intestine and enter blood. Heme Circulation Iron stored as ferritin, hemosiderin Bilirubin Bilirubin is picked up from blood by liver, secreted into intestine in bile, metabolized to stercobilin by bacteria, and excreted in feces.
Figure 17.7, step 1 Low O2   levels in blood stimulate kidneys to produce erythropoietin. 1
Figure 17.7, step 2 Low O2   levels in blood stimulate kidneys to produce erythropoietin. 1 Erythropoietin levels rise in blood. 2
Figure 17.7, step 3 Low O2   levels in blood stimulate kidneys to produce erythropoietin. 1 Erythropoietin levels rise in blood. 2 Erythropoietin and necessary raw materials in blood promote erythropoiesis in red bone marrow. 3
Figure 17.7, step 4 Low O2   levels in blood stimulate kidneys to produce erythropoietin. 1 Erythropoietin levels rise in blood. 2 Erythropoietin and necessary raw materials in blood promote erythropoiesis in red bone marrow. 3 New erythrocytes enter bloodstream; function about 120 days. 4
Figure 17.7, step 5 Aged and damaged red blood cells are engulfed by macrophages of liver, spleen, and bone marrow; the hemoglobin is broken down. 5 Hemoglobin Amino acids Globin Heme Circulation Iron stored as ferritin, hemosiderin Bilirubin Bilirubin is picked up from blood by liver, secreted into intestine in bile, metabolized to stercobilin by bacteria, and excreted in feces.
Figure 17.7, step 6 Aged and damaged red blood cells are engulfed by macrophages of liver, spleen, and bone marrow; the hemoglobin is broken down. 5 Raw materials are made available in blood for erythrocyte synthesis. 6 Hemoglobin Amino acids Globin Iron is bound to transferrin and released to blood from liver as needed for erythropoiesis. Food nutrients, including amino acids, Fe, B12, and folic acid, are absorbed from intestine and enter blood. Heme Circulation Iron stored as ferritin, hemosiderin Bilirubin Bilirubin is picked up from blood by liver, secreted into intestine in bile, metabolized to stercobilin by bacteria, and excreted in feces.
Figure 17.7 Low O 2   levels in blood stimulate  kidneys to produce erythropoietin. 1 Erythropoietin levels rise in blood. 2 Erythropoietin and necessary raw materials in blood promote erythropoiesis in red bone marrow. 3 Aged and damaged red blood cells are engulfed by macrophages of liver, spleen, and bone marrow; the hemoglobin is broken down. 5 New erythrocytes enter bloodstream; function about 120 days. 4 Raw materials are made available in blood for erythrocyte synthesis. 6 Hemoglobin Amino acids Globin Iron is bound to transferrin and released to blood from liver as needed for erythropoiesis. Food nutrients, including amino acids, Fe, B 12 , and folic acid, are absorbed from intestine and enter blood. Heme Circulation Iron stored as ferritin, hemosiderin Bilirubin Bilirubin is picked up from blood by liver, secreted into intestine in bile, metabolized to stercobilin by bacteria, and excreted in feces.
Erythrocyte Disorders ,[object Object],[object Object],[object Object],[object Object]
Causes of Anemia ,[object Object],[object Object],[object Object],[object Object]
Causes of Anemia ,[object Object],[object Object],[object Object],[object Object],[object Object]
Causes of Anemia ,[object Object],[object Object],[object Object],[object Object]
Causes of Anemia ,[object Object],[object Object],[object Object],[object Object]
Causes of Anemia ,[object Object],[object Object],[object Object]
Figure 17.8 1 2 3 4 5 6 7 146 1 2 3 4 5 6 7 146 (a) Normal erythrocyte has normal hemoglobin amino acid sequence in the beta chain. (b) Sickled erythrocyte results from a single amino acid change in the beta chain of hemoglobin.
Erythrocyte Disorders ,[object Object],[object Object],[object Object],[object Object],[object Object]
Leukocytes ,[object Object],[object Object],[object Object],[object Object],[object Object]
Figure 17.9 Formed elements Platelets Leukocytes Erythrocytes Differential WBC count (All total 4800   – 10,800/l) Neutrophils (50   –   70%) Lymphocytes (25 – 45%) Eosinophils (2   –   4%) Basophils (0.5   –   1%) Monocytes (3 – 8%) Agranulocytes Granulocytes
Granulocytes ,[object Object],[object Object],[object Object],[object Object],[object Object]
Neutrophils ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Eosinophils ,[object Object],[object Object],[object Object],[object Object]
Basophils ,[object Object],[object Object],[object Object],[object Object]
Figure 17.10 (a-c) (a) Neutrophil; multilobed nucleus (b) Eosinophil; bilobed nucleus,  red cytoplasmic  granules (c) Basophil; bilobed nucleus, purplish-black  cytoplasmic  granules
Agranulocytes ,[object Object],[object Object],[object Object]
Lymphocytes ,[object Object],[object Object],[object Object]
Lymphocytes ,[object Object],[object Object],[object Object]
Monocytes ,[object Object],[object Object],[object Object]
Monocytes ,[object Object],[object Object],[object Object]
Figure 17.10d, e (d) Small lymphocyte; large spherical  nucleus (e) Monocyte; kidney-shaped nucleus
Table 17.2 (1 of 2)
Table 17.2 (2 of 2)
Leukopoiesis ,[object Object],[object Object],[object Object],[object Object],[object Object]
Figure 17.11 Hemocytoblast Myeloid stem cell Lymphoid stem cell Myeloblast Myeloblast Monoblast Myeloblast Lymphoblast Stem cells Committed cells Promyelocyte Promyelocyte Promyelocyte Promonocyte Prolymphocyte Eosinophilic myelocyte Neutrophilic myelocyte Basophilic myelocyte Eosinophilic band cells Neutrophilic band cells Basophilic band cells Developmental pathway Eosinophils Neutrophils Basophils Granular leukocytes (a) (b) (c) (d) (e) Monocytes Lymphocytes Agranular leukocytes Some become Some become
Leukocyte Disorders ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Leukemia ,[object Object],[object Object],[object Object],[object Object]
Platelets ,[object Object],[object Object],[object Object],[object Object]
Platelets ,[object Object],[object Object]
Figure 17.12 Stem cell Developmental pathway Hemocyto- blast Megakaryoblast Promegakaryocyte Megakaryocyte Platelets
Hemostasis ,[object Object],[object Object],[object Object],[object Object]
Vascular Spasm ,[object Object],[object Object],[object Object],[object Object],[object Object]
Platelet Plug Formation ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Figure 17.13 Collagen fibers Platelets Fibrin Step  Vascular spasm •   Smooth muscle contracts, causing vasoconstriction. Step  Platelet plug formation •   Injury to lining of vessel exposes collagen fibers; platelets adhere. •   Platelets release chemicals that make nearby platelets sticky; platelet plug forms. Step  Coagulation •   Fibrin forms a mesh that traps red blood cells and platelets, forming the clot. 1 2 3
Coagulation ,[object Object],[object Object]
Coagulation ,[object Object],[object Object],[object Object],[object Object]
Figure 17.14 (1 of 2) Vessel endothelium ruptures, exposing underlying tissues (e.g., collagen) PF 3 released by aggregated platelets XII XI IX XII a Ca 2+ Ca 2+ XI a IX a Intrinsic pathway Phase 1 Tissue cell trauma exposes blood to Platelets cling and their surfaces provide sites for mobilization of factors Extrinsic pathway Tissue factor (TF) VII VII a VIII VIII a Ca 2+ X X a Prothrombin activator PF 3 TF/VII a   complex IXa/VIII a   complex V V a
Figure 17.14 (2 of 2) Ca 2+ Phase 2  Phase 3  Prothrombin activator Prothrombin (II) Thrombin (II a ) Fibrinogen (I) (soluble) Fibrin (insoluble polymer) XIII  XIII a Cross-linked fibrin mesh
Coagulation Phase 1: Two Pathways to Prothrombin Activator ,[object Object],[object Object],[object Object],[object Object],[object Object]
Coagulation Phase 1: Two Pathways to Prothrombin Activator ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Coagulation Phase 2: Pathway to Thrombin ,[object Object]
Coagulation Phase 3: Common Pathway to the Fibrin Mesh ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Figure 17.15
Clot Retraction ,[object Object],[object Object]
Clot Repair ,[object Object],[object Object]
Fibrinolysis ,[object Object],[object Object],[object Object]
Factors Limiting Clot Growth or Formation ,[object Object],[object Object],[object Object]
Inhibition of Clotting Factors ,[object Object],[object Object],[object Object]
Factors Preventing Undesirable Clotting ,[object Object],[object Object],[object Object],[object Object]
Disorders of Hemostasis ,[object Object],[object Object]
Thromboembolytic Conditions ,[object Object],[object Object],[object Object],[object Object],[object Object]
Thromboembolytic Conditions ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Disseminated Intravascular Coagulation (DIC) ,[object Object],[object Object],[object Object]
Bleeding Disorders ,[object Object],[object Object],[object Object],[object Object],[object Object]
Bleeding Disorders ,[object Object],[object Object],[object Object],[object Object]
Bleeding Disorders ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Transfusions ,[object Object],[object Object],[object Object]
Human Blood Groups ,[object Object],[object Object],[object Object],[object Object],[object Object]
Blood Groups ,[object Object],[object Object],[object Object]
ABO Blood Groups ,[object Object],[object Object],[object Object],[object Object]
Table 17.4
Rh Blood Groups ,[object Object],[object Object],[object Object]
Rh Blood Groups ,[object Object],[object Object],[object Object]
Homeostatic Imbalance: Hemolytic Disease of the Newborn ,[object Object],[object Object],[object Object]
Homeostatic Imbalance: Hemolytic Disease of the Newborn ,[object Object],[object Object]
Transfusion Reactions ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Blood Typing ,[object Object],[object Object]
ABO Blood Typing
Figure 17.16 Serum Anti-A RBCs Anti-B Type AB  (contains agglutinogens A and B; agglutinates with both sera) Blood being tested Type A  (contains agglutinogen A; agglutinates with anti-A) Type B  (contains agglutinogen B; agglutinates with anti-B) Type O   (contains no agglutinogens; does not agglutinate with either serum)
Restoring Blood Volume  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Diagnostic Blood Tests ,[object Object],[object Object],[object Object]
Diagnostic Blood Tests ,[object Object],[object Object],[object Object],[object Object]
Developmental Aspects ,[object Object],[object Object],[object Object],[object Object]
Developmental Aspects ,[object Object],[object Object],[object Object]

Weitere ähnliche Inhalte

Was ist angesagt?

Non-Surgical Management of PPH
Non-Surgical Management of PPHNon-Surgical Management of PPH
Non-Surgical Management of PPHlimgengyan
 
Thromboembolism in pregnancy
Thromboembolism in pregnancyThromboembolism in pregnancy
Thromboembolism in pregnancyhanaa adnan
 
Breech presentation
Breech presentationBreech presentation
Breech presentationchricres
 
Thromboprophylaxis in pregnancy and puerperium
Thromboprophylaxis in pregnancy and puerperiumThromboprophylaxis in pregnancy and puerperium
Thromboprophylaxis in pregnancy and puerperiumManju Puri
 
obstetric emergencies panel discussion.
obstetric emergencies panel discussion.obstetric emergencies panel discussion.
obstetric emergencies panel discussion.Raji Kanth
 
Breech Presentation & transverse lie.ppt
Breech Presentation & transverse lie.pptBreech Presentation & transverse lie.ppt
Breech Presentation & transverse lie.pptabdelnaser5
 
Management of hyperemesis gravidarum guidelines - copy
Management of hyperemesis gravidarum  guidelines - copy Management of hyperemesis gravidarum  guidelines - copy
Management of hyperemesis gravidarum guidelines - copy Lifecare Centre
 
Post partum haemorrhage
Post partum haemorrhagePost partum haemorrhage
Post partum haemorrhageAlpit Gandhi
 
Surgical management of pph at tertiary center
Surgical management of pph at tertiary centerSurgical management of pph at tertiary center
Surgical management of pph at tertiary centerdrmcbansal
 
MMgt of hypertensive disorders in preg
MMgt of hypertensive disorders in pregMMgt of hypertensive disorders in preg
MMgt of hypertensive disorders in pregPave Medicine
 
autoimmune diseases in pregnancy
autoimmune diseases in pregnancy autoimmune diseases in pregnancy
autoimmune diseases in pregnancy Abdullah Abdurrhman
 
unexplained recurrent pregnancy loss case scenario
unexplained recurrent pregnancy loss case scenariounexplained recurrent pregnancy loss case scenario
unexplained recurrent pregnancy loss case scenarioAhmed Mosad
 

Was ist angesagt? (20)

Non-Surgical Management of PPH
Non-Surgical Management of PPHNon-Surgical Management of PPH
Non-Surgical Management of PPH
 
Cesarean delivery on maternal request
Cesarean delivery on maternal requestCesarean delivery on maternal request
Cesarean delivery on maternal request
 
Thromboembolism in pregnancy
Thromboembolism in pregnancyThromboembolism in pregnancy
Thromboembolism in pregnancy
 
Supply chain management 1
Supply chain management 1Supply chain management 1
Supply chain management 1
 
Breech presentation
Breech presentationBreech presentation
Breech presentation
 
Thromboprophylaxis in pregnancy and puerperium
Thromboprophylaxis in pregnancy and puerperiumThromboprophylaxis in pregnancy and puerperium
Thromboprophylaxis in pregnancy and puerperium
 
obstetric emergencies panel discussion.
obstetric emergencies panel discussion.obstetric emergencies panel discussion.
obstetric emergencies panel discussion.
 
Breech Presentation & transverse lie.ppt
Breech Presentation & transverse lie.pptBreech Presentation & transverse lie.ppt
Breech Presentation & transverse lie.ppt
 
Dvt in pregnancy
Dvt in pregnancyDvt in pregnancy
Dvt in pregnancy
 
Management of hyperemesis gravidarum guidelines - copy
Management of hyperemesis gravidarum  guidelines - copy Management of hyperemesis gravidarum  guidelines - copy
Management of hyperemesis gravidarum guidelines - copy
 
Maternal obstetric injuries for undergraduate
Maternal obstetric injuries for undergraduateMaternal obstetric injuries for undergraduate
Maternal obstetric injuries for undergraduate
 
Near miss
Near missNear miss
Near miss
 
Post partum haemorrhage
Post partum haemorrhagePost partum haemorrhage
Post partum haemorrhage
 
Surgical management of pph at tertiary center
Surgical management of pph at tertiary centerSurgical management of pph at tertiary center
Surgical management of pph at tertiary center
 
Iufd
IufdIufd
Iufd
 
MMgt of hypertensive disorders in preg
MMgt of hypertensive disorders in pregMMgt of hypertensive disorders in preg
MMgt of hypertensive disorders in preg
 
Trauma in pregnancy
Trauma in pregnancyTrauma in pregnancy
Trauma in pregnancy
 
autoimmune diseases in pregnancy
autoimmune diseases in pregnancy autoimmune diseases in pregnancy
autoimmune diseases in pregnancy
 
Thalassemia and Pregnancy
Thalassemia and PregnancyThalassemia and Pregnancy
Thalassemia and Pregnancy
 
unexplained recurrent pregnancy loss case scenario
unexplained recurrent pregnancy loss case scenariounexplained recurrent pregnancy loss case scenario
unexplained recurrent pregnancy loss case scenario
 

Ähnlich wie Ch 17 lecture_outline

Ähnlich wie Ch 17 lecture_outline (20)

Blood1
Blood1Blood1
Blood1
 
Blood Physiology.pptx
Blood Physiology.pptxBlood Physiology.pptx
Blood Physiology.pptx
 
Anemias interpretation of cbc 2010rev
Anemias   interpretation of cbc 2010revAnemias   interpretation of cbc 2010rev
Anemias interpretation of cbc 2010rev
 
ERYTHROPOIESIS.pptx
ERYTHROPOIESIS.pptx ERYTHROPOIESIS.pptx
ERYTHROPOIESIS.pptx
 
pathology - Hematology
pathology - Hematology pathology - Hematology
pathology - Hematology
 
Blood ppt
Blood pptBlood ppt
Blood ppt
 
2. blood physiology
2. blood physiology2. blood physiology
2. blood physiology
 
Blood physiology
Blood physiologyBlood physiology
Blood physiology
 
Red blood cell formation and fate of RBC
Red blood cell formation and fate of RBCRed blood cell formation and fate of RBC
Red blood cell formation and fate of RBC
 
blood physiology
blood physiologyblood physiology
blood physiology
 
Chap18 blood
Chap18 bloodChap18 blood
Chap18 blood
 
Anatomy And Physiology
Anatomy And PhysiologyAnatomy And Physiology
Anatomy And Physiology
 
mbbs ims msu
mbbs ims msumbbs ims msu
mbbs ims msu
 
Blood
BloodBlood
Blood
 
Blood1 140214151708-phpapp01
Blood1 140214151708-phpapp01Blood1 140214151708-phpapp01
Blood1 140214151708-phpapp01
 
Blood Overview PPT
Blood Overview PPTBlood Overview PPT
Blood Overview PPT
 
Hematologic disorders
Hematologic disordersHematologic disorders
Hematologic disorders
 
Blood (RBC, Anemia, Polycythemia)
Blood (RBC, Anemia, Polycythemia)Blood (RBC, Anemia, Polycythemia)
Blood (RBC, Anemia, Polycythemia)
 
Week6 RBC:an explanation on the process of RBC formation
Week6 RBC:an explanation on the process of RBC formationWeek6 RBC:an explanation on the process of RBC formation
Week6 RBC:an explanation on the process of RBC formation
 
Blood Erythrocytes (red blood cells) Leukocytes (white blood cells) Platelets...
Blood Erythrocytes (red blood cells) Leukocytes (white blood cells) Platelets...Blood Erythrocytes (red blood cells) Leukocytes (white blood cells) Platelets...
Blood Erythrocytes (red blood cells) Leukocytes (white blood cells) Platelets...
 

Ch 17 lecture_outline

  • 2.
  • 3.
  • 4. Figure 17.1 1 Withdraw blood and place in tube. 2 Centrifuge the blood sample. Plasma • 55% of whole blood • Least dense component Buffy coat • Leukocytes and platelets • <1% of whole blood Erythrocytes • 45% of whole blood • Most dense component Formed elements
  • 5.
  • 6.
  • 7.
  • 8.
  • 9.
  • 10.
  • 11.
  • 12. Figure 17.2 Platelets Neutrophils Lymphocyte Erythrocytes Monocyte
  • 13.
  • 14. Figure 17.3 2.5 µm 7.5 µm Side view (cut) Top view
  • 15.
  • 16.
  • 17.
  • 18. Figure 17.4 Heme group (a) Hemoglobin consists of globin (two alpha and two beta polypeptide chains) and four heme groups. (b) Iron-containing heme pigment.  Globin chains  Globin chains
  • 19.
  • 20.
  • 21.
  • 22.
  • 23.
  • 24. Figure 17.5 Stem cell Hemocytoblast Proerythro- blast Early erythroblast Late erythroblast Normoblast Phase 1 Ribosome synthesis Phase 2 Hemoglobin accumulation Phase 3 Ejection of nucleus Reticulo- cyte Erythro- cyte Committed cell Developmental pathway
  • 25.
  • 26.
  • 27.
  • 28.
  • 29. Figure 17.6 Kidney (and liver to a smaller extent) releases erythropoietin. Erythropoietin stimulates red bone marrow. Enhanced erythropoiesis increases RBC count. O 2 - carrying ability of blood increases. Homeostasis: Normal blood oxygen levels Stimulus: Hypoxia (low blood O 2 - carrying ability) due to • Decreased RBC count • Decreased amount of hemoglobin • Decreased availability of O 2 1 2 3 4 5 IMBALANCE IMBALANCE
  • 30. Figure 17.6, step 1 Homeostasis: Normal blood oxygen levels Stimulus: Hypoxia (low blood O 2 - carrying ability) due to • Decreased RBC count • Decreased amount of hemoglobin • Decreased availability of O 2 1 IMBALANCE IMBALANCE
  • 31. Figure 17.6, step 2 Kidney (and liver to a smaller extent) releases erythropoietin. Homeostasis: Normal blood oxygen levels Stimulus: Hypoxia (low blood O 2 - carrying ability) due to • Decreased RBC count • Decreased amount of hemoglobin • Decreased availability of O 2 1 2 IMBALANCE IMBALANCE
  • 32. Figure 17.6, step 3 Kidney (and liver to a smaller extent) releases erythropoietin. Erythropoietin stimulates red bone marrow. Homeostasis: Normal blood oxygen levels Stimulus: Hypoxia (low blood O 2 - carrying ability) due to • Decreased RBC count • Decreased amount of hemoglobin • Decreased availability of O 2 1 2 3 IMBALANCE IMBALANCE
  • 33. Figure 17.6, step 4 Kidney (and liver to a smaller extent) releases erythropoietin. Erythropoietin stimulates red bone marrow. Enhanced erythropoiesis increases RBC count. Homeostasis: Normal blood oxygen levels Stimulus: Hypoxia (low blood O 2 - carrying ability) due to • Decreased RBC count • Decreased amount of hemoglobin • Decreased availability of O 2 1 2 3 4 IMBALANCE IMBALANCE
  • 34. Figure 17.6, step 5 Kidney (and liver to a smaller extent) releases erythropoietin. Erythropoietin stimulates red bone marrow. Enhanced erythropoiesis increases RBC count. O 2 - carrying ability of blood increases. Homeostasis: Normal blood oxygen levels Stimulus: Hypoxia (low blood O 2 - carrying ability) due to • Decreased RBC count • Decreased amount of hemoglobin • Decreased availability of O 2 1 2 3 4 5 IMBALANCE IMBALANCE
  • 35.
  • 36.
  • 37.
  • 38. Figure 17.7 Low O 2 levels in blood stimulate kidneys to produce erythropoietin. 1 Erythropoietin levels rise in blood. 2 Erythropoietin and necessary raw materials in blood promote erythropoiesis in red bone marrow. 3 Aged and damaged red blood cells are engulfed by macrophages of liver, spleen, and bone marrow; the hemoglobin is broken down. 5 New erythrocytes enter bloodstream; function about 120 days. 4 Raw materials are made available in blood for erythrocyte synthesis. 6 Hemoglobin Amino acids Globin Iron is bound to transferrin and released to blood from liver as needed for erythropoiesis. Food nutrients, including amino acids, Fe, B 12 , and folic acid, are absorbed from intestine and enter blood. Heme Circulation Iron stored as ferritin, hemosiderin Bilirubin Bilirubin is picked up from blood by liver, secreted into intestine in bile, metabolized to stercobilin by bacteria, and excreted in feces.
  • 39. Figure 17.7, step 1 Low O2 levels in blood stimulate kidneys to produce erythropoietin. 1
  • 40. Figure 17.7, step 2 Low O2 levels in blood stimulate kidneys to produce erythropoietin. 1 Erythropoietin levels rise in blood. 2
  • 41. Figure 17.7, step 3 Low O2 levels in blood stimulate kidneys to produce erythropoietin. 1 Erythropoietin levels rise in blood. 2 Erythropoietin and necessary raw materials in blood promote erythropoiesis in red bone marrow. 3
  • 42. Figure 17.7, step 4 Low O2 levels in blood stimulate kidneys to produce erythropoietin. 1 Erythropoietin levels rise in blood. 2 Erythropoietin and necessary raw materials in blood promote erythropoiesis in red bone marrow. 3 New erythrocytes enter bloodstream; function about 120 days. 4
  • 43. Figure 17.7, step 5 Aged and damaged red blood cells are engulfed by macrophages of liver, spleen, and bone marrow; the hemoglobin is broken down. 5 Hemoglobin Amino acids Globin Heme Circulation Iron stored as ferritin, hemosiderin Bilirubin Bilirubin is picked up from blood by liver, secreted into intestine in bile, metabolized to stercobilin by bacteria, and excreted in feces.
  • 44. Figure 17.7, step 6 Aged and damaged red blood cells are engulfed by macrophages of liver, spleen, and bone marrow; the hemoglobin is broken down. 5 Raw materials are made available in blood for erythrocyte synthesis. 6 Hemoglobin Amino acids Globin Iron is bound to transferrin and released to blood from liver as needed for erythropoiesis. Food nutrients, including amino acids, Fe, B12, and folic acid, are absorbed from intestine and enter blood. Heme Circulation Iron stored as ferritin, hemosiderin Bilirubin Bilirubin is picked up from blood by liver, secreted into intestine in bile, metabolized to stercobilin by bacteria, and excreted in feces.
  • 45. Figure 17.7 Low O 2 levels in blood stimulate kidneys to produce erythropoietin. 1 Erythropoietin levels rise in blood. 2 Erythropoietin and necessary raw materials in blood promote erythropoiesis in red bone marrow. 3 Aged and damaged red blood cells are engulfed by macrophages of liver, spleen, and bone marrow; the hemoglobin is broken down. 5 New erythrocytes enter bloodstream; function about 120 days. 4 Raw materials are made available in blood for erythrocyte synthesis. 6 Hemoglobin Amino acids Globin Iron is bound to transferrin and released to blood from liver as needed for erythropoiesis. Food nutrients, including amino acids, Fe, B 12 , and folic acid, are absorbed from intestine and enter blood. Heme Circulation Iron stored as ferritin, hemosiderin Bilirubin Bilirubin is picked up from blood by liver, secreted into intestine in bile, metabolized to stercobilin by bacteria, and excreted in feces.
  • 46.
  • 47.
  • 48.
  • 49.
  • 50.
  • 51.
  • 52. Figure 17.8 1 2 3 4 5 6 7 146 1 2 3 4 5 6 7 146 (a) Normal erythrocyte has normal hemoglobin amino acid sequence in the beta chain. (b) Sickled erythrocyte results from a single amino acid change in the beta chain of hemoglobin.
  • 53.
  • 54.
  • 55. Figure 17.9 Formed elements Platelets Leukocytes Erythrocytes Differential WBC count (All total 4800 – 10,800/l) Neutrophils (50 – 70%) Lymphocytes (25 – 45%) Eosinophils (2 – 4%) Basophils (0.5 – 1%) Monocytes (3 – 8%) Agranulocytes Granulocytes
  • 56.
  • 57.
  • 58.
  • 59.
  • 60. Figure 17.10 (a-c) (a) Neutrophil; multilobed nucleus (b) Eosinophil; bilobed nucleus, red cytoplasmic granules (c) Basophil; bilobed nucleus, purplish-black cytoplasmic granules
  • 61.
  • 62.
  • 63.
  • 64.
  • 65.
  • 66. Figure 17.10d, e (d) Small lymphocyte; large spherical nucleus (e) Monocyte; kidney-shaped nucleus
  • 67. Table 17.2 (1 of 2)
  • 68. Table 17.2 (2 of 2)
  • 69.
  • 70. Figure 17.11 Hemocytoblast Myeloid stem cell Lymphoid stem cell Myeloblast Myeloblast Monoblast Myeloblast Lymphoblast Stem cells Committed cells Promyelocyte Promyelocyte Promyelocyte Promonocyte Prolymphocyte Eosinophilic myelocyte Neutrophilic myelocyte Basophilic myelocyte Eosinophilic band cells Neutrophilic band cells Basophilic band cells Developmental pathway Eosinophils Neutrophils Basophils Granular leukocytes (a) (b) (c) (d) (e) Monocytes Lymphocytes Agranular leukocytes Some become Some become
  • 71.
  • 72.
  • 73.
  • 74.
  • 75. Figure 17.12 Stem cell Developmental pathway Hemocyto- blast Megakaryoblast Promegakaryocyte Megakaryocyte Platelets
  • 76.
  • 77.
  • 78.
  • 79. Figure 17.13 Collagen fibers Platelets Fibrin Step Vascular spasm • Smooth muscle contracts, causing vasoconstriction. Step Platelet plug formation • Injury to lining of vessel exposes collagen fibers; platelets adhere. • Platelets release chemicals that make nearby platelets sticky; platelet plug forms. Step Coagulation • Fibrin forms a mesh that traps red blood cells and platelets, forming the clot. 1 2 3
  • 80.
  • 81.
  • 82. Figure 17.14 (1 of 2) Vessel endothelium ruptures, exposing underlying tissues (e.g., collagen) PF 3 released by aggregated platelets XII XI IX XII a Ca 2+ Ca 2+ XI a IX a Intrinsic pathway Phase 1 Tissue cell trauma exposes blood to Platelets cling and their surfaces provide sites for mobilization of factors Extrinsic pathway Tissue factor (TF) VII VII a VIII VIII a Ca 2+ X X a Prothrombin activator PF 3 TF/VII a complex IXa/VIII a complex V V a
  • 83. Figure 17.14 (2 of 2) Ca 2+ Phase 2 Phase 3 Prothrombin activator Prothrombin (II) Thrombin (II a ) Fibrinogen (I) (soluble) Fibrin (insoluble polymer) XIII XIII a Cross-linked fibrin mesh
  • 84.
  • 85.
  • 86.
  • 87.
  • 89.
  • 90.
  • 91.
  • 92.
  • 93.
  • 94.
  • 95.
  • 96.
  • 97.
  • 98.
  • 99.
  • 100.
  • 101.
  • 102.
  • 103.
  • 104.
  • 105.
  • 107.
  • 108.
  • 109.
  • 110.
  • 111.
  • 112.
  • 114. Figure 17.16 Serum Anti-A RBCs Anti-B Type AB (contains agglutinogens A and B; agglutinates with both sera) Blood being tested Type A (contains agglutinogen A; agglutinates with anti-A) Type B (contains agglutinogen B; agglutinates with anti-B) Type O (contains no agglutinogens; does not agglutinate with either serum)
  • 115.
  • 116.
  • 117.
  • 118.
  • 119.